![Whitchurch-Stouffville, On, Canada: - May 30, 2021: Teva Canada Ltd facility in Whitchurch-Stouffville, On, Canada. Teva Pharmaceutical Industries Ltd. is an Israeli pharmaceutical company. foto de Stock | Adobe Stock Whitchurch-Stouffville, On, Canada: - May 30, 2021: Teva Canada Ltd facility in Whitchurch-Stouffville, On, Canada. Teva Pharmaceutical Industries Ltd. is an Israeli pharmaceutical company. foto de Stock | Adobe Stock](https://as2.ftcdn.net/v2/jpg/04/36/57/51/1000_F_436575157_YIgOV2zm0fdJmC2d6gTPtCHosyfUzJNN.jpg)
Whitchurch-Stouffville, On, Canada: - May 30, 2021: Teva Canada Ltd facility in Whitchurch-Stouffville, On, Canada. Teva Pharmaceutical Industries Ltd. is an Israeli pharmaceutical company. foto de Stock | Adobe Stock
Company Update (NYSE:TEVA): Teva Pharmaceutical Industries Ltd (ADR) Sells Off Last of Specialty Global Women's Health Portfolio Assets in $1.38 Billion Deal
TEVA PHARMACEUTICAL INDUSTRIES LIMITED : Precio Acción Bourse | TEVA | IL0006290147 | MarketScreener
![Teva Pharmaceutical Industries Ltd. is moving its North American headquarters from North Wales, Mo… | Teva pharmaceuticals, Pharmaceutical industry, Pharmaceutical Teva Pharmaceutical Industries Ltd. is moving its North American headquarters from North Wales, Mo… | Teva pharmaceuticals, Pharmaceutical industry, Pharmaceutical](https://i.pinimg.com/736x/c0/59/0a/c0590aa49ec6e8fa8a3b8bba206b5362.jpg)
Teva Pharmaceutical Industries Ltd. is moving its North American headquarters from North Wales, Mo… | Teva pharmaceuticals, Pharmaceutical industry, Pharmaceutical
![Resumen: Teva recibe la autorización de comercialización de la UE para Seffalair® Spiromax® y BroPair® Spiromax® (xinafoato de salmeterol/propionato de fluticasona) | Business Wire Resumen: Teva recibe la autorización de comercialización de la UE para Seffalair® Spiromax® y BroPair® Spiromax® (xinafoato de salmeterol/propionato de fluticasona) | Business Wire](https://mms.businesswire.com/media/20210408005428/es/739014/22/teva_RGB_JPEG.jpg)